The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – A systematic review of in vitro data
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
Lewinski, N., Colvin, V., & Drezek, R. (2008) · Small · doi:10.1002/smll.200700595 · Cited by 2,810
Trypan Blue Exclusion Test of Cell Viability
Strober, W. (2015) · Current Protocols in Immunology · doi:10.1002/0471142735.ima03bs111 · Cited by 2,597
Neutral red uptake assay for the estimation of cell viability/cytotoxicity
Repetto, G., del Peso, A., & Zurita, J. L. (2008) · Nature Protocols · doi:10.1038/nprot.2008.75 · Cited by 2,207
Fotakis, G., & Timbrell, J. A. (2006) · Toxicology Letters · doi:10.1016/j.toxlet.2005.07.001 · Cited by 1,558
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
Pardeike, J., Hommoss, A., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.003 · Cited by 1,478
Trypan Blue Exclusion Test of Cell Viability
Strober, W. (1997) · Current Protocols in Immunology · doi:10.1002/0471142735.ima03bs21 · Cited by 1,345
Biochemistry of Oxidative Stress
Sies, H. (1986) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198610581 · Cited by 1,306
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Yang, H., Liu, C., Yang, D., Zhang, H., & Xi, Z. (2009) · Journal of Applied Toxicology · doi:10.1002/jat.1385 · Cited by 1,087
Long, T. C., Saleh, N., Tilton, R. D., Lowry, G. V., & Veronesi, B. (2006) · Environmental Science & Technology · doi:10.1021/es060589n · Cited by 870
Müller, R. H., Gohla, S., & Keck, C. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.01.007 · Cited by 702
Tarpey, M. M., Wink, D. A., & Grisham, M. B. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00361.2003 · Cited by 673
Chen, X., Zhong, Z., Xu, Z., Chen, L., & Wang, Y. (2010) · Free Radical Research · doi:10.3109/10715761003709802 · Cited by 548
20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications
H. Muller, R., Shegokar, R., & M. Keck, C. (2011) · Current Drug Discovery Technologies · doi:10.2174/157016311796799062 · Cited by 544
Jores, K., Mehnert, W., Drechsler, M., Bunjes, H., Johann, C., & Mäder, K. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.11.012 · Cited by 472
Müller, R. H., Mehnert, W., Lucks, J. S., Schwarz, C., Mühlen, A. Z., Meyhers, H., de Freitas, C. F., & Rühl, D. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 455
Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery
Battaglia, L., & Gallarate, M. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.673278 · Cited by 400
Gokce, E., Korkmaz, Dellera, Sandri, Bonferoni, & Ozer, O. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29710 · Cited by 323
Paclitaxel nanoparticles for the potential treatment of brain tumors
Koziara, J. M., Lockman, P. R., Allen, D. D., & Mumper, R. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.006 · Cited by 299
Schubert, M. A., & Müller-Goymann, C. C. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.03.006 · Cited by 297
The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol
Teskač, K., & Kristl, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.011 · Cited by 288
YUAN, H., MIAO, J., DU, Y., YOU, J., HU, F., & ZENG, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.012 · Cited by 275
Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant
Müller, R. H., Rühl, D., Runge, S., Schulze-Forster, K., & Mehnert, W. (1997) · Pharmaceutical Research · doi:10.1023/a:1012043315093 · Cited by 265
Mulik, R. S., Mönkkönen, J., Juvonen, R. O., Mahadik, K. R., & Paradkar, A. R. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.021 · Cited by 260
Patlolla, R. R., Chougule, M., Patel, A. R., Jackson, T., Tata, P. N. V., & Singh, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.006 · Cited by 250
Lee, M.-K., Lim, S.-J., & Kim, C.-K. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.01.014 · Cited by 248
Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel
Liu, D., Liu, Z., Wang, L., Zhang, C., & Zhang, N. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.02.038 · Cited by 245
Müller, R., Maaben, S., Weyhers, H., & Mehnert, W. (1996) · Journal of Drug Targeting · doi:10.3109/10611869609015973 · Cited by 222
Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug
Jain, A., Agarwal, A., Majumder, S., Lariya, N., Khaya, A., Agrawal, H., Majumdar, S., & Agrawal, G. P. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.09.003 · Cited by 217
Kakkar, V., & Kaur, I. P. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.08.006 · Cited by 212
Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA
Olbrich, C., Bakowsky, U., Lehr, C.-M., Müller, R. H., & Kneuer, C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00506-5 · Cited by 181
Miglietta, A., Cavalli, R., Bocca, C., Gabriel, L., & Rosa Gasco, M. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00562-7 · Cited by 180
Nassimi, M., Schleh, C., Lauenstein, H. D., Hussein, R., Hoymann, H. G., Koch, W., Pohlmann, G., Krug, N., Sewald, K., Rittinghausen, S., et al. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.02.014 · Cited by 173
Martins, S., Costa-Lima, S., Carneiro, T., Cordeiro-da-Silva, A., Souto, E. B., & Ferreira, D. C. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.032 · Cited by 165
Self-citationMagdolénová, Z., Bilaničová, D., Pojana, G., Fjellsbø, L. M., Hudecova, A. M., Hašplová, K., Marcomini, A., & Dušinská, M. (2012) · Journal of Environmental Monitoring · doi:10.1039/c2em10746e · Cited by 165
Serpe, L., Catalano, M. G., Cavalli, R., Ugazio, E., Bosco, O., Canaparo, R., Muntoni, E., Frairia, R., Gasco, M. R., Eandi, M., et al. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.026 · Cited by 165
Cyclosporine A loaded SLNs: Evaluation of cellular uptake and corneal cytotoxicity
Gokce, E. H., Sandri, G., Bonferoni, M. C., Rossi, S., Ferrari, F., Güneri, T., & Caramella, C. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.028 · Cited by 159
Picone, P., Bondì, M. L., Picone, P., Bondì, M. L., Montana, G., Bruno, A., Pitarresi, G. L., Giammona, G., & Carlo, M. D. (2009) · Free Radical Research · doi:10.1080/10715760903214454 · Cited by 156
Tabatt, K., Sameti, M., Olbrich, C., Müller, R. H., & Lehr, C. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.10.015 · Cited by 152
Schöler, N., Hahn, H. H., Müller, R. H., & Liesenfeld, O. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00882-1 · Cited by 149
Schöler, N., Olbrich, C., Tabatt, K., Müller, R. H., Hahn, H. H., & Liesenfeld, O. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00660-3 · Cited by 145
Martins, S. M., Sarmento, B. F. C. C., Nunes, C., Lúcio, M., Reis, S., & Ferreira, D. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.08.011 · Cited by 142
Kim, H. R., Kim, I. K., Bae, K. H., Hyeon, L. S., Lee, Y., & Park, T. G. (2008) · Molecular Pharmaceutics · doi:10.1021/mp8000233 · Cited by 139
Vitorino, C., Almeida, J., Gonçalves, L., Almeida, A. J., Sousa, J., & Pais, A. A. C. C. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.02.011 · Cited by 138
Mannan-Modified Solid Lipid Nanoparticles for Targeted Gene Delivery to Alveolar Macrophages
Yu, W., Liu, C., Liu, Y., Zhang, N., & Xu, W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0149-z · Cited by 137
Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect
Videira, M., Almeida, A. J., & Fabra, À. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.12.007 · Cited by 130
Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles
Koziara, J. M., Oh, J. J., Akers, W. S., Ferraris, S. P., & Mumper, R. J. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7547-7 · Cited by 125
Martins, S., Tho, I., Reimold, I., Fricker, G., Souto, E. B., Ferreira, D., & Brandl, M. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.054 · Cited by 120
Self-citationSilva, A. C., Kumar, A., Wild, W., Ferreira, D., Santos, D. F. G., & Forbes, B. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.058 · Cited by 118
Self-citationSolid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands
Pedersen, N. M., Hansen, S. H., Heydenreich, A. V., Kristensen, H. G., & Poulsen, H. S. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.09.003 · Cited by 117
Shen, J., Deng, Y., Jin, X., Ping, Q., Su, Z., & Li, L. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.008 · Cited by 116
Development of a highly stable and targetable nanoliposomal formulation of topotecan
Drummond, D. C., Noble, C. O., Guo, Z., Hayes, M. E., Connolly-Ingram, C., Gabriel, B. S., Hann, B. C., Liu, B., Park, J. W., & Hong, K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.006 · Cited by 115
Mussi, S. V., Silva, R. C., Oliveira, M. C., Lucci, C. M., Azevedo, R. B., & Ferreira, L. A. M. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.10.025 · Cited by 113
Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticles
Chuan, J., Li, Y., Yang, L., Sun, X., Zhang, Q., Gong, T., & Zhang, Z. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1634-1 · Cited by 107
Trombino, S., Cassano, R., Muzzalupo, R., Pingitore, A., Cione, E., & Picci, N. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.03.032 · Cited by 107
Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles
Venishetty, V. K., Komuravelli, R., Kuncha, M., Sistla, R., & Diwan, P. V. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.03.003 · Cited by 104
Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis
Lopes, R. M., Eleutério, C., Gonçalves, L., Cruz, M. E. M., & Almeida, A. J. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.09.017 · Cited by 103
Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application
Weyenberg, W., Filev, P., den Plas, D. V., et al. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.045 · Cited by 101
Heydenreich, A. V. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00688-9 · Cited by 98
Formulation of tenofovir‐loaded functionalized solid lipid nanoparticles intended for HIV prevention
Alukda, D., Sturgis, T. F., & Youan, B.-B. C. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22529 · Cited by 98
Low cytotoxicity of solid lipid nanoparticles inin vitroandex vivolung models
Nassimi, M., Schleh, C., Lauenstein, H.-D., Hussein, R., Lübbers, K., Pohlmann, G., Switalla, S., Sewald, K., Müller, M., Krug, N., et al. (2009) · Inhalation Toxicology · doi:10.1080/08958370903005769 · Cited by 98
Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design
Carbone, C., Tomasello, B., Ruozi, B., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.01.001 · Cited by 97
Freitas, C., & Müller, R. H. (1999) · Journal of Microencapsulation · doi:10.1080/026520499289310 · Cited by 94
Influences of opioids and nanoparticles on in vitro wound healing models
Wolf, N. B., Hedtrich, S., Radowski, M. R., Blaschke, T., Kramer, K. D., Weindl, G., Kleuser, B., Haag, R., & Schäfer‐Korting, M. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.03.009 · Cited by 93
Ruktanonchai, U., Bejrapha, P., Sakulkhu, U., Opanasopit, P., Bunyapraphatsara, N., Junyaprasert, V. B., & Puttipipatkhachorn, S. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9193-6 · Cited by 93
In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain
Montenegro, L., Campisi, A., Sarpietro, M., Carbone, C., Acquaviva, R., Raciti, G., & Puglisi, G. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2010.539231 · Cited by 92
Asasutjarit, R., Lorenzen, S.-I., Sirivichayakul, S., Ruxrungtham, K., Ruktanonchai, U., & Ritthidej, G. C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9234-3 · Cited by 89
Ozer, Ö., Gokce, E. H., Tanrıverdi, S. T., Korkmaz, Sandri, G., Bonferoni, M. C., & Dellera, E. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s34921 · Cited by 86
Gokce, E. H., Sandri, G., Eğrilmez, S., Bonferoni, M. C., Güneri, T., & Caramella, C. M. (2009) · Current Eye Research · doi:10.3109/02713680903261405 · Cited by 84
Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy
Zhang, N., Wang, & Li (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s32520 · Cited by 77
Kong, W. H., Park, K., Lee, M. Y., Lee, H., Sung, D. K., & Hahn, S. K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.067 · Cited by 77
Bondì, M. L., Craparo, E. F., Giammona, G., Cervello, M., Azzolina, A., Diana, P., Martorana, A., & Cirrincione, G. (2007) · Drug Delivery · doi:10.1080/10717540600739914 · Cited by 73
Schwarz, J. C., Weixelbaum, A., Pagitsch, E., Löw, M., Resch, G. P., & Valenta, C. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.08.003 · Cited by 71
Bondì, M. L., Montana, G., Craparo, E. F., Picone, P., Capuano, G., Carlo, M. D., & Giammona, G. (2009) · Current Nanoscience · doi:10.2174/157341309787314656 · Cited by 70
Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells
Kuo, Y., & Liang, C.-T. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.02.011 · Cited by 64
Yuan, L., Zhang, Z., Wei, C., Zhou, L., Wu, Q., & Chen (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s34991 · Cited by 62
Comet assay reveals no genotoxicity risk of cationic solid lipid nanoparticles
Doktorovová, S., Silva, A. M., Gaivão, I., Souto, E. B., Teixeira, J. P., & Martins‐Lopes, P. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2961 · Cited by 61
Self-citationThe efficacy and safety of bufadienolides-loaded nanostructured lipid carriers
Li, F., Weng, Y., Wang, L., He, H., Yang, J., & Tang, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.005 · Cited by 60
The physical state of lipid nanoparticles influences their effect on in vitro cell viability
Petersen, S., Steiniger, F., Fischer, D., Fahr, A., & Bunjes, H. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.03.022 · Cited by 55
Erni, C., Suard, C., Freitas, S., Dreher, D., Merkle, H. P., & Walter, E. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00216-8 · Cited by 53
Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery
Yu, W., Liu, C., Ye, J., Zou, W., Zhang, N., & Xu, W. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/21/215102 · Cited by 53
Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility
Potta, S. G., Minemi, S., Nukala, R. K., Peinado, C., Lamprou, D. A., Urquhart, A. J., & Douroumis, D. (2010) · Journal of Microencapsulation · doi:10.3109/02652048.2010.529948 · Cited by 52
Ling, D., Bae, B.-C., Park, W., & Na, K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.023 · Cited by 50
Khajavinia, A., Varshosaz, J., & Jafarian‐Dehkordi, A. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/40/405101 · Cited by 47
Olbrich, C., Schöler, N., Tabatt, K., et al. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023754 · Cited by 44
Agarwal, A., Majumder, S., Agrawal, H., Majumdar, S., & Agrawal, G. P. (2011) · Current Nanoscience · doi:10.2174/157341311794480291 · Cited by 43
In vitro biocompatibility of solid lipid nanoparticles
Silva, A. H., Filippin-Monteiro, F. B., Mattei, B., Zanetti-Ramos, B. G., & Creczynski‐Pasa, T. B. (2012) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2012.06.018 · Cited by 42
Self-citationFerreira, L. A. M., Carneiro, G., Silva, Pacheco, de Souza-Fagundes, E. M., Goes, Oliveira, M. C., & Correa (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s38953 · Cited by 41
Cytotoxicity Effect of Solid Lipid Nanoparticles on Human Breast Cancer Cell Lines
Abbasalipourkabir, R., Salehzadeh, A., & Abdullah, R. (2011) · Biotechnology(Faisalabad) · doi:10.3923/biotech.2011.528.533 · Cited by 40
Olbrich, C., Müller, R. H., Tabatt, K., Kayser, O., Schulze, C., & Schade, R. (2002) · Alternatives to Laboratory Animals · doi:10.1177/026119290203000407 · Cited by 37
Lipid nanoparticles for chemotherapeutic applications: strategies to improve anticancer efficacy
Lin, X., Gao, R., Zhang, Y., Qi, N., Zhang, Y. L., Zhang, K., He, H., & Tang, X. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.685933 · Cited by 24
Varshosaz, J., Hassanzadeh, F., Sadeghi, H., & Shakery, M. (2012) · Current Nanoscience · doi:10.2174/157341312800167542 · Cited by 14
Vighi, E., Leo, E., Montanari, M., Mucci, A., Hanuskovà, M., & Iannuccelli, V. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.118 · Cited by 11
Editorial: The Imperative to Authenticate Cell Lines
Healey, J. H. (2010) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-010-1585-0 · Cited by 5
Cited by
Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology
Zielińska, A., Carreiró, F., Oliveira, A. M., Neves, A., Pires, B., Venkatesh, D. N., Durazzo, A., Lucarini, M., Eder, P., Silva, A. M., et al. (2020) · Molecules · doi:10.3390/molecules25163731 · Cited by 1,560
Self-citationSolid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application
Naseri, N., Valizadeh, H., & Zakeri-Milani, P. (2015) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2015.043 · Cited by 1,116
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Nanoparticles and targeted drug delivery in cancer therapy
Bahrami, B., Hojjat-Farsangi, M., Mohammadi, H., Anvari, E., Ghalamfarsa, G., Yousefi, M., & Jadidi-Niaragh, F. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.07.015 · Cited by 510
Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review
Haider, M., Abdin, S. M., Kamal, L., & Orive, G. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030288 · Cited by 451
Metadata
- Authors
- Doktorovova, S., Souto, E. B., & Silva, A. M.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 87
- Issue
- 1
- Pages
- 1-18
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2036861909
- Cited by
- 419
- References
- 97
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.